文献速递脑血管病

无创通气校正用于急性缺血性卒中:系统综述与荟萃分析

Noninvasive Ventilatory Correction in Patients With Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
PubMed 文献 · Stroke · 2017-06-08

该系统综述与荟萃分析纳入4项随机临床试验和1项前瞻性匹配观察队列,共389例急性缺血性卒中患者,评估无创通气校正对神经功能改善、血管事件和死亡的影响。结果显示无创通气校正组在急性期前30天内NIHSS评分下降更显著,但血管事件风险和死亡率与对照组无显著差异。结论提示无创通气校正可能改善短期神经功能,需进一步开展足够样本量的假对照随机试验验证。

要点

  • 无创通气校正组前30天NIHSS评分下降优于对照组(SMD 0.38,95%CI 0.11-0.66,P=0.007)。
  • 血管事件风险(RR 0.53,95%CI 0.25-1.14,P=0.11)和死亡率(RR 0.71,95%CI 0.37-1.36,P=0.30)无显著差异。
  • 多数纳入随机试验因缺乏盲法存在高偏倚风险,证据需进一步验证。

核心结论

  • 无创通气校正可能改善伴阻塞性睡眠呼吸暂停的急性缺血性卒中患者的短期神经功能。

研究设计与样本

  • 系统综述与荟萃分析,纳入4项随机临床试验和1项前瞻性匹配观察队列,共389例患者(男性59.8%,平均年龄64.4岁)。

主要发现

  • 无创通气校正组前30天NIHSS评分平均下降幅度大于对照组(SMD 0.38,95%CI 0.11-0.66,P=0.007)。
  • 两组血管事件风险无显著差异(RR 0.53,95%CI 0.25-1.14,P=0.11)。
  • 两组死亡率无显著差异(RR 0.71,95%CI 0.37-1.36,P=0.30)。
  • 所有分析未检测到异质性(I2=0%,Cochran Q的P>0.50)或发表偏倚。

关键数值与推荐

  • 神经功能改善基于NIHSS评分下降。
  • 血管事件包括复发性卒中、短暂性脑缺血发作、心肌梗死和不稳定型心绞痛。

临床怎么用

  • 对于伴阻塞性睡眠呼吸暂停的急性缺血性卒中患者,可考虑使用无创通气校正以促进短期神经功能改善。
  • 当前证据不足以支持无创通气校正降低血管事件风险或死亡率。

局限性

  • 多数纳入随机临床试验因参与者、人员和/或结局评估者缺乏盲法而存在高实施偏倚和检测偏倚风险。
  • 迄今无足够样本量的随机临床试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Even though current guidelines suggest that noninvasive ventilatory correction (NIVC) could be considered for acute ischemic stroke patients with obstructive sleep apnea, available evidence is conflicting, with no adequately powered randomized clinical trial being available to date. METHODS: We conducted a systematic review and meta-analysis of all available literature data evaluating the effect of NIVC on neurological improvement (based on decrease in National Institutes of Health Stroke Scale score), vascular events (recurrent stroke, transient ischemic attack, myocardial infarction and unstable angina), and mortality during the follow-up period. RESULTS: We identified 4 randomized clinical trials and 1 prospectively matched observational cohort, comprising a total of 389 patients (59.8% males, mean age: 64.4 years). The risk of both performance and detection bias was considered high in most of the included randomized clinical trials because of the lack of blinding in participants, personnel and/or outcome assessors. The mean decrease in National Institutes of Health Stroke Scale scores during the first (≤30) days of acute ischemic stroke was found to be greater in NIVC-treated patients in comparison to controls (standardized mean difference, 0.38; 95% confidence interval, 0.11-0.66; P=0.007). However, no significant differences were detected between NIVC-treated acute ischemic stroke patients and controls on both the risk of vascular events (risk ratio, 0.53; 95% confidence interval, 0.25-1.14; P=0.11) and mortality (risk ratio, 0.71; 95% confidence interval, 0.37-1.36; P=0.30). No evidence of heterogeneity (I2=0%; P for Cochran Q>0.50) or publication bias were detected in all analyses. CONCLUSIONS: NIVC seems to be associated with greater short-term neurological improvement in acute ischemic stroke patients with obstructive sleep apnea. This finding deserves further investigation within the settings of an adequately powered, sham-control, randomized clinical trial.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Tsivgoulis G, Alexandrov AV, Katsanos AH, et al. Noninvasive Ventilatory Correction in Patients With Acute Ischemic Stroke: A Systematic Review and Meta-Analysis. Stroke. 2017. PMID: 28596449. doi:10.1161/STROKEAHA.117.017661

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。